Skip to main content
Premium Trial:

Request an Annual Quote

Genetron Health Nabs CE Mark for Blood Cancer Residual Disease Test Kit

NEW YORK – Genetron Health said today that it has received a CE mark for its proprietary human B lymphocyte minimal residual disease detection test kit, Seq-MRD, enabling the kit to be sold in the European Union and other countries that recognize the CE mark.

The assay is designed to detect the CDR3 regional sequence of the IgH/K/L gene of the B cell receptor in bone marrow samples collected from patients with B lymphocytic leukemia and multiple myeloma before and after treatment.

Based on Genetron's "One-step Seq" method, the kit allows DNA library construction to finish with a single PCR, minimizing the risks of sample contamination and false-positive results.

The Seq-MRD test joins a handful of other tests for which Genetron has received a CE mark, including PCR-based kits for IDH1 and TERT gene promoter mutation kits, and various tumor sequencing panels.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.